Tata India Pharma & Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank -
BMSMONEY Rating
Gro. Opt. As On: 20-12-2024
NAV ₹30.82(R) -0.81% ₹35.53(D) -0.81%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 42.34% 22.77% 27.39% 19.8% -%
LumpSum (D) 44.44% 24.6% 29.31% 21.68% -%
SIP (R) -22.5% 27.72% 24.43% 23.5% -%
SIP (D) -21.25% 29.66% 26.29% 25.35% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.87 0.5 0.85 3.32% 0.15
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.22% -14.79% -14.52% 0.92 10.13%
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Dsp Healthcare Fund -
Tata India Pharma & Healthcare Fund -
Uti Healthcare Fund -

NAV Date: 20-12-2024

Scheme Name NAV Rupee Change Percent Change
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option 30.82
-0.2500
-0.8100%
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option 30.82
-0.2500
-0.8100%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 30.82
-0.2500
-0.8100%
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option 35.53
-0.2900
-0.8100%
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option 35.53
-0.2900
-0.8100%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 35.53
-0.2900
-0.8100%

Review Date: 20-12-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It reflects the surge in the investment's value throughout the investment period, communicated as a percentage or a specific monetary sum. Our analysis encompassed six return parameters of this fund. We have organized the return parameters into three performance groups for evaluation: the top 25%, parameters that rank below the top 25% but above average, and parameters that are below average. Below, you'll find a breakdown of how each parameter has performed.
    1. Top 25%: One return parameter of the Tata India Pharma & Healthcare Fund is in the top 25% in the category, as listed below:
      • 1M Return %
    2. Above Average Below the Top 25%: The Tata India Pharma & Healthcare Fund has one return parameter in the category, which is above average but below the top 25%, as listed below:
      • 3Y Return %
    3. Below Average: Tata India Pharma & Healthcare Fund has four return parameters that are below average in the category, which are listed below:
      • 1Y Return %
      • 5Y Return %
      • 6M Return %
      • 3M Return %
  2. Risk: The threat of not realizing projected profits or even facing financial loss due to different issues is known as risk. For Tata India Pharma & Healthcare Fund, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: one risk parameter in the lowest 25% in the category, which is listed below.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.13 %.
    2. Below Average but Above the Lowest 25%: Tata India Pharma & Healthcare Fund has one risk parameter that is below average but above the lowest 25% in the category. These are:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.22 %.
    3. Above Average: Tata India Pharma & Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: Risk-adjusted performance parameters in mutual funds are parameters that assess the return on investments based on the risks involved. These parameters provide a platform for investors to compare various investments, by considering both profits and the risks involved. For Tata India Pharma & Healthcare Fund, we have evaluated four risk-adjusted performance parameters.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: Tata India Pharma & Healthcare Fund has two risk-adjusted performance parameters of the fund that are in the this group of the category.
      • Sterling Ratio: Tata India Pharma & Healthcare Fund has a Sterling Ratio of 0.85 compared to the category average of 0.8.
      • Sortino Ratio: Tata India Pharma & Healthcare Fund has a Sortino Ratio of 0.5 compared to the category average of 0.48.
    3. Below Average Risk Adjusted Performance Parameters: Tata India Pharma & Healthcare Fund has two risk-adjusted performance parameters of the fund that are below average in the category.
      • Sharpe Ratio: Tata India Pharma & Healthcare Fund has a Sharpe Ratio of 0.87 compared to the category average of 0.88.
      • Treynor Ratio: Tata India Pharma & Healthcare Fund has a Treynor Ratio of 0.15 compared to the category average of 0.15.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 4.52
2.88
-0.97 | 4.52 1 | 13 Very Good
3M Return % -0.57
-0.40
-9.73 | 3.09 9 | 13 Average
6M Return % 17.70
19.11
3.40 | 26.27 10 | 13 Average
1Y Return % 42.34
42.49
33.84 | 51.93 7 | 12 Average
3Y Return % 22.77
22.41
19.56 | 25.88 4 | 8 Good
5Y Return % 27.39
28.25
24.23 | 30.74 7 | 8 Poor
7Y Return % 19.80
19.20
18.29 | 20.24 2 | 4 Good
1Y SIP Return % -22.50
-21.85
-35.24 | -12.91 8 | 12 Average
3Y SIP Return % 27.72
28.17
25.24 | 32.64 5 | 8 Average
5Y SIP Return % 24.43
24.81
21.75 | 27.67 5 | 8 Average
7Y SIP Return % 23.50
23.68
23.30 | 24.58 2 | 4 Good
Standard Deviation 15.22
15.42
14.47 | 16.13 3 | 8 Good
Semi Deviation 10.13
10.54
10.13 | 10.91 2 | 8 Very Good
Max Drawdown % -14.52
-16.50
-18.92 | -14.27 2 | 8 Very Good
VaR 1 Y % -14.79
-16.74
-18.91 | -14.68 2 | 8 Very Good
Average Drawdown % -4.22
-5.35
-6.76 | -4.22 1 | 8 Very Good
Sharpe Ratio 0.87
0.88
0.66 | 1.12 4 | 8 Good
Sterling Ratio 0.85
0.80
0.66 | 1.02 3 | 8 Good
Sortino Ratio 0.50
0.48
0.36 | 0.65 4 | 8 Good
Jensen Alpha % 3.32
4.05
0.12 | 8.16 5 | 8 Average
Treynor Ratio 0.15
0.15
0.11 | 0.19 5 | 8 Average
Modigliani Square Measure % 22.46
22.51
18.32 | 27.03 4 | 8 Good
Alpha % 1.76
2.41
-0.61 | 6.00 5 | 8 Average
Return data last Updated On : Dec. 20, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 4.64 2.99 -0.84 | 4.64 1 | 13
3M Return % -0.22 -0.08 -9.36 | 3.54 9 | 13
6M Return % 18.55 19.88 4.26 | 27.36 10 | 13
1Y Return % 44.44 44.30 36.04 | 53.85 6 | 12
3Y Return % 24.60 23.89 21.29 | 27.00 4 | 8
5Y Return % 29.31 29.86 26.17 | 32.66 5 | 8
7Y Return % 21.68 20.56 19.50 | 21.68 1 | 4
1Y SIP Return % -21.25 -20.75 -34.00 | -11.70 8 | 12
3Y SIP Return % 29.66 29.75 27.01 | 33.82 5 | 8
5Y SIP Return % 26.29 26.34 23.54 | 28.81 4 | 8
7Y SIP Return % 25.35 25.06 24.40 | 25.90 2 | 4
Standard Deviation 15.22 15.42 14.47 | 16.13 3 | 8
Semi Deviation 10.13 10.54 10.13 | 10.91 2 | 8
Max Drawdown % -14.52 -16.50 -18.92 | -14.27 2 | 8
VaR 1 Y % -14.79 -16.74 -18.91 | -14.68 2 | 8
Average Drawdown % -4.22 -5.35 -6.76 | -4.22 1 | 8
Sharpe Ratio 0.87 0.88 0.66 | 1.12 4 | 8
Sterling Ratio 0.85 0.80 0.66 | 1.02 3 | 8
Sortino Ratio 0.50 0.48 0.36 | 0.65 4 | 8
Jensen Alpha % 3.32 4.05 0.12 | 8.16 5 | 8
Treynor Ratio 0.15 0.15 0.11 | 0.19 5 | 8
Modigliani Square Measure % 22.46 22.51 18.32 | 27.03 4 | 8
Alpha % 1.76 2.41 -0.61 | 6.00 5 | 8
Return data last Updated On : Dec. 20, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -0.81 ₹ 9,919.00 -0.81 ₹ 9,919.00
1W 1.35 ₹ 10,135.00 1.38 ₹ 10,138.00
1M 4.52 ₹ 10,452.00 4.64 ₹ 10,464.00
3M -0.57 ₹ 9,943.00 -0.22 ₹ 9,978.00
6M 17.70 ₹ 11,770.00 18.55 ₹ 11,855.00
1Y 42.34 ₹ 14,234.00 44.44 ₹ 14,444.00
3Y 22.77 ₹ 18,503.00 24.60 ₹ 19,344.00
5Y 27.39 ₹ 33,552.00 29.31 ₹ 36,159.00
7Y 19.80 ₹ 35,413.00 21.68 ₹ 39,483.00
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -22.50 ₹ 10,481.75 -21.25 ₹ 10,569.37
3Y ₹ 36000 27.72 ₹ 53,699.51 29.66 ₹ 55,122.73
5Y ₹ 60000 24.43 ₹ 109,903.92 26.29 ₹ 114,927.96
7Y ₹ 84000 23.50 ₹ 194,111.40 25.35 ₹ 207,232.37
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Tata India Pharma & Healthcare Fund NAV Regular Growth Tata India Pharma & Healthcare Fund NAV Direct Growth
20-12-2024 30.8171 35.5256
19-12-2024 31.0685 35.814
18-12-2024 30.6942 35.3811
17-12-2024 30.4443 35.0917
16-12-2024 30.6379 35.3135
13-12-2024 30.406 35.0419
12-12-2024 30.4928 35.1407
11-12-2024 30.731 35.4138
10-12-2024 30.6418 35.3095
09-12-2024 30.6749 35.3463
06-12-2024 30.8085 35.496
05-12-2024 30.781 35.463
04-12-2024 30.7758 35.4555
03-12-2024 30.7325 35.4042
02-12-2024 30.7071 35.3736
29-11-2024 30.4821 35.1102
28-11-2024 29.8565 34.3883
27-11-2024 29.8596 34.3906
26-11-2024 29.9647 34.5102
25-11-2024 30.2029 34.7831
22-11-2024 29.8174 34.3351
21-11-2024 29.4834 33.9492

Fund Launch Date: 04/Dec/2015
Fund Category: Pharma Fund
Investment Objective: The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
Fund Description: A) Pharmaceuticals and Healthcare services sector oriented Fund b) Ideal for investors seeking focused investments in Health service and Medicine realated sectors
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.